CME Group Inc. CME
264.48
(4.43)
(1.65%)
as of 25 Sep
- Market cap
- $96.5B
- P/E
- 22.3×
Follow CME
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
CME Group Inc. (CME) P/E ratio
As of 25 September 2026, CME Group Inc. (CME) trades at a P/E ratio of 22.3×. Over the past ten years it has ranged from 12.1× (January 2018) to 43.4× (September 2019); the current reading is higher than 11% of that period. That is in line with the Financial Data & Stock Exchanges industry median of 21.8× and above the Financial sector median of 12.6×.
P/E ratio, daily
Annual
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 24.4× | 1.92% |
| FY2024 | 24.0× | 1.60% |
| FY2023 | 23.6× | 3.46% |
| FY2022 | 22.8× | (26.95%) |
| FY2021 | 31.2× | 0.81% |
| FY2020 | 31.0× | (8.68%) |
| FY2019 | 33.9× | 3.45% |
| FY2018 | 32.8× | 171.40% |
| FY2017 | 12.1× | (52.08%) |
| FY2016 | 25.2× | 3.18% |
Quarterly
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2026 | 18.6× | (25.73%) |
| Mar 2026 | 25.0× | 2.47% |
| Dec 2025 | 24.4× | (6.61%) |
| Sep 2025 | 26.2× | (1.78%) |
| 42 more quarters | Free account |
Against its own ten years
Low 12.1×
High 43.4×
Ten-year median
25.7×
Current reading's percentile
11
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| COIN Coinbase Global, Inc. compare | n/m |
| TRU TransUnion compare | 18.1× |
| CBOE Cboe Global Markets, Inc. compare | 20.0× |
| ICE Intercontinental Exchange Inc. compare | 21.7× |
| CME CME Group Inc. | 22.3× |
| SPGI S&P Global Inc. compare | 24.6× |
| NDAQ Nasdaq, Inc. compare | 27.0× |
| MCO Moody's Corporation compare | 29.6× |
| MSCI MSCI Inc compare | 30.1× |
| Financial Data & Stock Exchanges industry median | 21.8× |
| Financial sector median | 12.6× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on CME
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement